Detection of coexisting toxigenic <i>Clostridium difficile</i> and nontyphoidal <i>Salmonella</i> in a healthcare worker with diarrhea: A therapeutic dilemma.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 31548964.
- Also identified by DOI 10.4103/jfmpc.jfmpc_227_19 and PMC identifier 6753814.
- Licence recorded as CC BY-NC-SA.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<i>Clostridium difficile</i> infection (CDI) and nontyphoidal <i>Salmonella</i> infection (NSI) have similar clinical manifestations and are seldom seen simultaneously. The decision-making in terms of antibiotic therapy becomes difficult when both the pathogens are isolated from the same patient. We describe a case of <i>Clostridium difficile</i> (CD) enterocolitis in a healthcare provider who concomitantly tested positive for nontyphoidal <i>Salmonella</i>. To the best of our knowledge after extensive literature review (English), this is only the fourth report highlighting this association. Although <i>Salmonella</i> is not a risk factor for CDI, it can cause intestinal inflammation and alteration in the intestinal flora. When two pathogens are isolated from the same patient, it is tempting to treat both with antibiotics as highlighted. When it involves healthcare workers, there is no difference in guidelines and should not be prescribed antibiotics with intent of reducing secondary transmission.